UBS reiterates Neutral rating on Apple stock as iPhone 17 demand peaks

UBS maintained a Neutral rating and $220 price target on Apple, citing data indicating that demand for the iPhone 17 lineup has passed its initial peak, with easing wait times for Pro models and muted interest in the Air version. This cautious outlook contrasts with Evercore ISI, which raised its price target to $290 based on strong upgrade potential, while Jefferies reiterated a Hold rating due to slowing momentum, reflecting mixed signals on the new iPhone's market reception.

Analysis

Wall Street presents a divided outlook on Apple's (AAPL) iPhone 17 cycle, creating uncertainty despite the stock trading near its 52-week high of $260.10. On the cautious side, UBS maintains a Neutral rating with a $220 target, citing its Evidence Lab data which indicates that demand has passed its initial peak. Specifically, UBS notes that wait times for the Pro model in China have eased to 13 days, below last year's level, and that demand for the Air model appears "muted." This view is echoed by Jefferies, which reiterated a Hold rating based on slowing momentum and shorter lead times in key Asian markets. In stark contrast, Evercore ISI raised its price target to $290, maintaining an Outperform rating based on a consumer survey that suggests a strong upgrade cycle driven by hardware improvements. Beyond the iPhone, Apple faces developments in AI, including an antitrust lawsuit from xAI, which it is moving to dismiss, and the internal development of an AI app named "Veritas" to overhaul Siri. This mix of weakening real-time demand indicators against positive survey sentiment and ongoing AI initiatives creates a complex investment picture.

Key Decisions for Investors

• Investors should prioritize monitoring hard data points, such as the iPhone wait times cited by UBS and Jefferies, over consumer survey sentiment to gauge the true strength of the current sales cycle.
• Given that Apple's stock is trading near its 52-week high, consider whether the current valuation fully accounts for the risk of decelerating demand highlighted by the neutral-to-cautious analyst reports.
• Track developments related to Apple's AI strategy, including the internal 'Veritas' project and the outcome of the xAI antitrust litigation, as these represent significant long-term catalysts or risks outside the immediate iPhone product cycle.